Therefore, the upregulation of SLC1A5 inhibits the production of MDA and upregulates GPX4 to reduce oxidative stress-related damage, thereby accelerating cell proliferation and promoting malignant tumor progression. This evidence concerns the gene SLC1A5 and cancer.